Aprogen Medicines Inc. (007460.KS) — Stock Score Summary

Aprogen Medicines Inc. (007460.KS) has a MoatMap StockRank of 4/100 based on Quality (10/100), Value (55/100), and Momentum (15/100) factor scores. The current signal is STRONG SELL. Aprogen Medicines lacks the scale, regulatory validation, and commercial-stage pricing power of leading global CDMOs. It is a highly speculative biotech player with weak cash generation, failing our quality compounder criteria.

Aprogen Medicines Inc. operates a dual business model encompassing industrial plant engineering and biopharmaceutical manufacturing. The company provides specialized insulation and maintenance services for heavy industries while leveraging its relationship with parent biotech Aprogen to manufacture biosimilars and antibody therapeutics. This structure provides a stable industrial revenue base to support its high-growth, capital-intensive biotechnology ventures.

Key Financial Metrics

Price$2.03
Market Cap$54M
Price/Book0.40
Return on Equity-32.7%
Return on Invested Capital-25.8%
Debt/Equity43.43
Gross Margin24.7%
Operating Margin-56.8%
Revenue Growth35.8%
Free Cash Flow$-67K

Aprogen Medicines Inc. operates in the Conglomerates industry, part of the Industrials sector (South Korea).

Frequently Asked Questions

What is Aprogen Medicines Inc.’s (007460.KS) StockRank?
MoatMap’s StockRank for Aprogen Medicines Inc. (007460.KS) is 4/100, with a Strong Sell signal. It is a composite of Quality (10), Value (55), and Momentum (15) factor ranks across MoatMap’s 19,000+ stock universe.
Does Aprogen Medicines Inc. have an economic moat?
Aprogen Medicines Inc. (007460.KS) has a Quality factor score of 10/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Aprogen Medicines Inc. a buy, hold, or sell?
MoatMap’s current signal for Aprogen Medicines Inc. (007460.KS) is Strong Sell, based on a StockRank of 4/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Aprogen Medicines Inc. in?
Aprogen Medicines Inc. (007460.KS) operates in the Industrials sector, specifically the Conglomerates industry (South Korea).
Browse all ranked stocks007460.KS deep dive reportAI ChampionsHow we score stocksSense-check another stock